Johnson and Johnson JNJ

Johnson & Johnson has revised its revenue forecast down to $93.3 billion to $94.3 billion for 2022, despite reporting $24 billion in quarterly sales, marking a 3% year-on-year growth. The company continues to raise its quarterly dividend by 6.6% to $1.13 per share, celebrating its 60th consecutive year of dividend growth. While navigating potential legal challenges and ongoing operational scrutiny, J&J maintains a strong financial position with a consistent record of increasing dividends and a favorable credit rating, ensuring it remains attractive to investors.